Article
Well-differentiated systemic mastocytosis showed excellent clinical response to imatinib in the absence of known molecular genetic abnormalities: A case report.
Medicine - 1 Oct 2016
Huang Lanshan, Wang Sa A, Konoplev Sergej, Bueso-Ramos Carlos E, Thakral Beenu, Miranda Roberto N, Jabbour Elias, Medeiros L Jeffrey, Kanagal-Shamanna Rashmi
Abstract excerpt
INTRODUCTION: Well-differentiated systemic mastocytosis (WDSM) is a rare, recently recognized provisional subvariant of systemic mastocytosis (SM). We report a case of WDSM that showed excellent clinical and cutaneous response to imatinib in the absence of known molecular genetic abnormalities. CLINICAL FINDINGS/DIAGNOSES: We present a 24-year-old woman with childhood onset of skin manifestations that progressed...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.